Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2018 / Articles / Nov / Coke Zero’d
Discovery & Development

Coke Zero’d

Genetically engineered skin cells expressing highly potent cocaine hydrolase reduce cocaine-seeking behavior in mice

By James Strachan 11/14/2018 0 min read

Share

Would addiction disappear if people could be “immunized” to a substance’s pleasurable effects? A team of researchers from the University of Chicago, US, have used gene-edited skin stem cells to protect mice from cocaine overdose and cocaine-seeking behavior (1) – and they hope to apply the same technology to other drugs, including alcohol and nicotine.

The work makes use of an enzyme found in hepatocytes and blood plasma called butyrylcholinesterase (BChE), which hydrolyzes cocaine into benzoic acid and ecgonine methyl ester – both low in toxicity and reward-inducing properties. Scientists have previously engineered a far more potent version of the enzyme, with more than 4,400 times higher catalytic efficiency. But modified BChE (hBChE) has a short half-life in the body when delivered via the parenteral route, rendering it useful only for the acute treatment of cocaine overdose, rather than long-term protection against addiction.

Instead, the researchers isolated mice skin cells and genetically engineered them (using CRISPR) to express and excrete hBChE. The modified skin cells were then transplanted back into the donor mice so that the more potent BChE protein could circulate in the blood and break down cocaine.

The results showed that the GhBChE mice exhibited significantly lower cocaine-seeking behavior compared with the wild-type (WT) mice. The GhBChE mice also showed a much faster cocaine clearance.

“There are no FDA approved methods for treating cocaine abuse so our approach has the potential to be the first one,” says Ming Xu, Professor of Anesthesia & Critical Care Director at the University of Chicago, and co-author of the study. Engineered skin stem cells and cultured epidermal autografts have been used to treat other skin diseases, including vitiligo and skin genetic disorders, and, according to the authors, regenerated skin grafts are stable and have been shown to survive long term in clinical follow-up studies. “We believe our approach is minimally invasive, highly efficient, low maintenance and affordable,” says Xu.

The authors do point out, however, that the development of drug abuse is accompanied by learned association between drug effects and environmental cues, which plays a significant role in cocaine. In other words, despite hBChE being a highly potent cocaine hydrolase, it is unlikely to affect cue-induced relapse.

“Human studies are now needed to find out how how big a skin patch is sufficient and how long it is effective in protecting against cocaine abuse – as well as whether there might be immune responses against the skin graft,” says Xu. “We hope to expand this approach to treating the abuse of other drugs, including alcohol and nicotine, as well as co-abuse.”

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Y. Li et al, “Genome-edited skin epidermal stem cells protect mice from cocaine-seeking behaviour and cocaine overdose”, Nature Biomedical Engineering (2018). DOI:10.1038/s41551-018-0293-z.

About the Author(s)

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

More Articles by James Strachan

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.